Erratum: Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: A randomized placebo-controlled trial (Therapeutic Advances in Cardiovascular Disease (2010) 4 (349-357) DOI: 10.1177/1753944710387629)

PunziH.; LewinA.; Luki?T.GoodinT.ChenW.

首页> 外文期刊>Therapeutic advances in cardiovascular disease >Erratum: Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: A randomized placebo-controlled trial (Therapeutic Advances in Cardiovascular Disease (2010) 4 (349-357) DOI: 10.1177/1753944710387629)

【24h】

Erratum: Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: A randomized placebo-controlled trial (Therapeutic Advances in Cardiovascular Disease (2010) 4 (349-357) DOI: 10.1177/1753944710387629)

机译：

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

This analysis was not post hoc: BMI was a stratification variable at randomization and a basis for a pre-specified additional subgroup analysis. The corrected sentence should read: "In a protocol-specified subgroup analysis, conducted to examine treatment effects based on baseline BMI status (30 kg/m2 obese), nebivolol..."

著录项

来源
《Therapeutic advances in cardiovascular disease》 |2011年第4期|213-213|共1页
作者
PunziH.; LewinA.; Luki?T.GoodinT.ChenW.;
展开▼
作者单位

Department of Biochemistry (IMRIC), Hebrew University-Hadassah Medical School, Ein Kerem, Jerusalem;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献

1. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Moderate Alzheimer's Disease (DRAMA) [J] . Shim YongSoo, Han Hyun Jeong, Park Kyung WonKim Byeong C.Park Kee HyungPark Mee YoungKim Hee-JinMoon So YoungChoi Seong HyePark Kun WooYang Dong WonYoon Soo JinKim Sang YunYoun Young ChulChoi HojinYoon Koung EunCho Hyun JuHan Seol-Heui Journal of Alzheimer's disease: JAD . 2022,第1期

机译：A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Moderate Alzheimer's Disease (DRAMA)
2. Efficacy and safety of bisoprolol 5 mg plus amlodipine 5 mg in patients with hypertension uncontrolled on monotherapy with 5 mg of amlodipine, a phase III multicenter, randomized, double-blind, placebo-controlled clinical trial - the AMCOR study [J] . Jedrusik Piotr, Placha Grzegorz, Gaciong ZbigniewAMCOR Trial Investigators Current medical research and opinion . 2023,第7期

机译：Efficacy and safety of bisoprolol 5 mg plus amlodipine 5 mg in patients with hypertension uncontrolled on monotherapy with 5 mg of amlodipine, a phase III multicenter, randomized, double-blind, placebo-controlled clinical trial - the AMCOR study
3. Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension-A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial [J] . Roham T. Zamanian, David Badesch, Lorinda ChungRobyn T. DomsicThomas MedsgerAshley PinckneyLynette Keyes-ElsteinCarla DAvetaMeagan SpychalaR. James WhitePaul M. HassounFerno TorresAndrew J. SweattJerry A. MolitorDinesh KhannaHolden MaeckerBeverly WelchEllen GoldmuntzMark R. Nicollson behalf of the NIH ASC01 Study Group American journal of respiratory and critical care medicine . 2021,第2期

机译：Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension-A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial

Erratum: Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: A randomized placebo-controlled trial (Therapeutic Advances in Cardiovascular Disease (2010) 4 (349-357) DOI: 10.1177/1753944710387629)

摘要

著录项

相似文献

相关主题

期刊订阅